NewsWhore
04-27-2012, 01:30 AM
Sanofi First-Quarter Net Climbs 13% on Genzyme, Lantus (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNH8-Hs0T9Ddf0TMb-SOodl-9rOYSQ&url=http://www.bloomberg.com/news/2012-04-27/sanofi-first-quarter-net-climbs-13-on-genzyme-lantus.html)
Bloomberg
First-quarter revenue from the newly reorganized Genzyme, on a constant structure basis and excluding currency fluctuations, climbed 14 percent to 400 million euros, with sales of Fabrazyme up 50 percent to 47 million euros. Pompe Disease Revenue from ...
and more » (http://news.google.com/news/more?ned=us&ncl=d8jOZlrbr_zci-M)
More... (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNH8-Hs0T9Ddf0TMb-SOodl-9rOYSQ&url=http://www.bloomberg.com/news/2012-04-27/sanofi-first-quarter-net-climbs-13-on-genzyme-lantus.html)
Bloomberg
First-quarter revenue from the newly reorganized Genzyme, on a constant structure basis and excluding currency fluctuations, climbed 14 percent to 400 million euros, with sales of Fabrazyme up 50 percent to 47 million euros. Pompe Disease Revenue from ...
and more » (http://news.google.com/news/more?ned=us&ncl=d8jOZlrbr_zci-M)
More... (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNH8-Hs0T9Ddf0TMb-SOodl-9rOYSQ&url=http://www.bloomberg.com/news/2012-04-27/sanofi-first-quarter-net-climbs-13-on-genzyme-lantus.html)